Zobrazeno 1 - 10
of 1 317
pro vyhledávání: ''
Autor:
Nicholas H Adamstein, Wolfgang Koenig, Peter Libby, Christian Weber, Paul M. Ridker, Marcus-André Deutsch, Oliver Soehnlein, Carina Mauersberger, Hendrik B. Sager, Quinte Braster, Avril A. B. Robertson, Jan Hettwer, Benedikt Miritsch, Mark E. Cooper, Heribert Schunkert, Markus Krane, Xinghai Li, Aldo Moggio, Julia Hinterdobler, Hermann Gram, Olaf Groß, Thorsten Kessler
Publikováno v:
Cardiovascular Research, 118(13):337, 2778-2791. Oxford University Press
AIMS: Targeting vascular inflammation represents a novel therapeutic approach to reduce complications of atherosclerosis. Neutralizing the pro-inflammatory cytokine interleukin-1β (IL-1β) using canakinumab, a monoclonal antibody, reduces the incide
Autor:
Bela Kubat, Bernard Depypere, Sebastiaan Maes, Renaat Coopman, Stan Monstrey, Karel E.Y. Claes, Nicolas S. Dhooghe, Michel Piette
Publikováno v:
Aesthetic Surgery Journal, 42(3), 231-238. Oxford University Press
Background Autologous facial fat grafting has gained popularity in recent years and is considered to be safe. This paper presents the case of a patient who died due to massive cerebral microfat embolism after facial fat grafting. Objectives The aim o
Publikováno v:
Neuro-oncology Advances
Melanoma is the most aggressive of the common forms of skin cancer. Metastasis to the central nervous system is one of the most common and deadly complications of this disease. Historically, melanoma patients with brain metastases had a median surviv
Publikováno v:
Neuro-oncology Advances
Brain metastases are a common occurrence in both non-small cell and small cell lung cancer with the potential to affect quality of life and prognosis. Due to concerns about the accessibility of the central nervous system by systemic chemotherapy agen
Autor:
Carl-Friedrich Hocher, Jian Li, Chang Chu, Sha Tang, Liang Hu, Bernhard K. Krämer, Huijun Chen, Ge Lin, Fei Gong, Benjamin Rösing, Sufen Cai, Berthold Hocher, Suimin Zeng
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
BackgroundThe risk of developing gestational diabetes mellitus (GDM) is higher in women undergoing assisted reproductive treatment than in women conceiving spontaneously.ObjectivesTo determine whether the GDM risk after day-3 embryo transfer differs
Autor:
Meng Meng Fan, Koji Takahashi, Makoto Arai, Izumi Ohno, Chikashi Ishioka, Yuichi Takiguchi, Akinobu Tawada
Publikováno v:
Japanese Journal of Clinical Oncology
Background According to a questionnaire sent to Designated Cancer Care Hospitals in Japan in 2013, only 39.4% of the institutes had medical oncology departments. Furthermore, most of these medical oncology departments were primarily responsible for t
Publikováno v:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
OBJECTIVES Although the incidence of perioperative stroke after cardiac surgery gradually decreased over the last decades, there is much variation between centres. This review aimed to create a concise overview of the evidence on possible surgical st
Publikováno v:
Rheumatology (Oxford, England)
Rheumatology, 60(7), 3088-3098. Oxford University Press
Rheumatology, 60(7), 3088-3098. Oxford University Press
A histologic hallmark of primary SS (pSS) is lymphocytic infiltration of the salivary and lacrimal glands, in particular by CD4+ T and B cells. In the early stages of the disease, infiltrates are dominated by CD4+ T cells, while B cell accumulation o
Autor:
Kazumasa Minami, Rika Kondo, Yuji Seo, Yutaka Takahashi, Keisuke Tamari, Hirofumi Yamamoto, Kazuhiko Ogawa, Fumiaki Isohashi, Takanori Adachi, Yuhki Yokoyama, Wantong Zhao, Daisuke Okuzaki, Masahiko Koizumi
Publikováno v:
Journal of Radiation Research
Radiation therapy is generally effective for treating breast cancers. However, approximately 30% of patients with breast cancer experience occasional post-treatment local and distant metastasis. Low-dose (0.5 Gy) irradiation is a risk factor that pro
Publikováno v:
Antibody Therapeutics
Background CD3-based bispecific T cell engagers (bsTCEs) are one of the most promising bispecific antibodies for effective cancer treatments. To elicit target-specific T cell-mediated cytotoxicity, these bsTCEs contain at least one binding unit direc